This is a Validated Antibody Database (VAD) review about human Mcl-1, based on 85 published articles (read how Labome selects the articles), using Mcl-1 antibody in all methods. It is aimed to help Labome visitors find the most suited Mcl-1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Mcl-1 synonym: BCL2L3; EAT; MCL1-ES; MCL1L; MCL1S; Mcl-1; TM; bcl2-L-3; mcl1/EAT

Knockout validation
Cell Signaling Technology
domestic rabbit monoclonal (D2W9E)
  • western blot knockout validation; mouse; loading ...; fig 4a
Cell Signaling Technology Mcl-1 antibody (Cell Signaling, 94296) was used in western blot knockout validation on mouse samples (fig 4a). Cell Death Differ (2021) ncbi
Abcam
domestic rabbit monoclonal (Y37)
  • western blot; human; 1:1000; loading ...; fig 4b, s1b
Abcam Mcl-1 antibody (Abcam, ab32087) was used in western blot on human samples at 1:1000 (fig 4b, s1b). Biol Open (2019) ncbi
domestic rabbit monoclonal (Y37)
  • western blot; human; 1:1000; loading ...; fig 5b
Abcam Mcl-1 antibody (Abcam, ab32087) was used in western blot on human samples at 1:1000 (fig 5b). Front Neurosci (2019) ncbi
domestic rabbit monoclonal (Y37)
  • western blot; human; 1:500; loading ...; fig 4b
Abcam Mcl-1 antibody (Abcam, ab32087) was used in western blot on human samples at 1:500 (fig 4b). Exp Ther Med (2016) ncbi
domestic rabbit monoclonal (Y37)
  • western blot; human; loading ...; fig 3a
Abcam Mcl-1 antibody (ABcam, ab32087) was used in western blot on human samples (fig 3a). Oncotarget (2016) ncbi
domestic rabbit monoclonal (Y37)
  • western blot; human; 1:500; fig 2
Abcam Mcl-1 antibody (Abcam, ab32087) was used in western blot on human samples at 1:500 (fig 2). Nat Commun (2016) ncbi
domestic rabbit monoclonal (Y37)
  • immunohistochemistry; human; 1:40; tbl 2
In order to evaluate the reliance on EBV or NF-kappaB signaling instead of B-cell receptor signaling in regards to complete phenotypic characterization of PTLD, Abcam Mcl-1 antibody (Abcam, ab32087) was used in immunohistochemistry on human samples at 1:40 (tbl 2). Hematol Oncol (2017) ncbi
domestic rabbit monoclonal (Y37)
  • western blot; human; fig 6
Abcam Mcl-1 antibody (Abcam, ab32087) was used in western blot on human samples (fig 6). Genetics (2015) ncbi
domestic rabbit monoclonal (Y37)
  • western blot; human; 1:500; fig 7
Abcam Mcl-1 antibody (Abcam, Y37) was used in western blot on human samples at 1:500 (fig 7). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (Y37)
  • western blot; human; 1:1000
Abcam Mcl-1 antibody (Abcam, ab32087) was used in western blot on human samples at 1:1000. Apoptosis (2014) ncbi
domestic rabbit monoclonal (Y37)
  • western blot; human; 1:500
Abcam Mcl-1 antibody (Abcam, ab32087) was used in western blot on human samples at 1:500. Autophagy (2013) ncbi
Santa Cruz Biotechnology
mouse monoclonal (G-7)
  • western blot; human; 1:1000; loading ...; fig 5e
Santa Cruz Biotechnology Mcl-1 antibody (Santa Cruz, sc-74437) was used in western blot on human samples at 1:1000 (fig 5e). Cell Death Dis (2021) ncbi
mouse monoclonal (22)
  • western blot; human; loading ...; fig 4f
Santa Cruz Biotechnology Mcl-1 antibody (Santa, sc-12756) was used in western blot on human samples (fig 4f). J Clin Invest (2019) ncbi
mouse monoclonal (22)
  • western blot; human; loading ...; fig 6a
Santa Cruz Biotechnology Mcl-1 antibody (Santa Cruz, SC-12756) was used in western blot on human samples (fig 6a). Nat Commun (2017) ncbi
mouse monoclonal (22)
  • western blot; human; fig 4
Santa Cruz Biotechnology Mcl-1 antibody (Santa Cruz, sc-12756) was used in western blot on human samples (fig 4). Oncotarget (2016) ncbi
mouse monoclonal (RC13)
  • western blot; human
In order to assess the effect of matrine on STAT3 signaling in cholangiocarcinoma cells, Santa Cruz Biotechnology Mcl-1 antibody (Santa Cruz, sc-56152) was used in western blot on human samples . Pharmacol Rep (2015) ncbi
mouse monoclonal (22)
  • western blot; human; fig 2
Santa Cruz Biotechnology Mcl-1 antibody (santa Cruz, SC-12756) was used in western blot on human samples (fig 2). Cancer Cell Int (2015) ncbi
mouse monoclonal (22)
  • western blot; human; loading ...; fig 2a
Santa Cruz Biotechnology Mcl-1 antibody (Santa Cruz, sc-12756) was used in western blot on human samples (fig 2a). Cell Death Dis (2014) ncbi
mouse monoclonal (22)
  • western blot; human; fig 6
Santa Cruz Biotechnology Mcl-1 antibody (Santa Cruz Biotechnology, sc-12756) was used in western blot on human samples (fig 6). Cell Death Differ (2010) ncbi
Invitrogen
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2a
Invitrogen Mcl-1 antibody (Invitrogen, PA5-27597) was used in western blot on human samples (fig 2a). Oncotarget (2018) ncbi
Rockland Immunochemicals
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig s5
Rockland Immunochemicals Mcl-1 antibody (Rockland, 200-401-CR9) was used in western blot on mouse samples (fig s5). J Clin Invest (2017) ncbi
Boster
domestic rabbit polyclonal
  • immunocytochemistry; mouse; loading ...; fig 7a
  • western blot; mouse; loading ...; fig 7g
  • immunoprecipitation; human; loading ...; fig 1c
  • immunocytochemistry; human; loading ...; fig 2a
  • western blot; human; loading ...; fig s1a
Boster Mcl-1 antibody (oster Biological Technology, PB9132) was used in immunocytochemistry on mouse samples (fig 7a), in western blot on mouse samples (fig 7g), in immunoprecipitation on human samples (fig 1c), in immunocytochemistry on human samples (fig 2a) and in western blot on human samples (fig s1a). J Cell Sci (2017) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D2W9E)
  • western blot; mouse; loading ...; fig s4c
Cell Signaling Technology Mcl-1 antibody (Cell signaling, 94296S) was used in western blot on mouse samples (fig s4c). Redox Biol (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3c
Cell Signaling Technology Mcl-1 antibody (Cell Signaling, 4572) was used in western blot on human samples (fig 3c). Cancers (Basel) (2021) ncbi
domestic rabbit monoclonal (D2W9E)
  • western blot; human; fig 2d
Cell Signaling Technology Mcl-1 antibody (Cell Signaling Technology, 94296) was used in western blot on human samples (fig 2d). Nat Commun (2021) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; 1:500; loading ...; fig s5a, s5b
  • western blot; mouse; 1:500; loading ...; fig 4h
Cell Signaling Technology Mcl-1 antibody (Cell Signaling, 5453) was used in western blot on human samples at 1:500 (fig s5a, s5b) and in western blot on mouse samples at 1:500 (fig 4h). NPJ Breast Cancer (2021) ncbi
domestic rabbit monoclonal (D2W9E)
  • western blot knockout validation; mouse; loading ...; fig 4a
Cell Signaling Technology Mcl-1 antibody (Cell Signaling, 94296) was used in western blot knockout validation on mouse samples (fig 4a). Cell Death Differ (2021) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; loading ...; fig 4d
Cell Signaling Technology Mcl-1 antibody (Cell Signaling Technology, 5453) was used in western blot on human samples (fig 4d). J Hematol Oncol (2020) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; 1:1000; loading ...; fig 1a
Cell Signaling Technology Mcl-1 antibody (Cell Signaling Technology, 5453) was used in western blot on human samples at 1:1000 (fig 1a). elife (2020) ncbi
domestic rabbit monoclonal (D2W9E)
  • western blot; human; 1:1000; loading ...; fig 3e
Cell Signaling Technology Mcl-1 antibody (Cell Signaling, 94296) was used in western blot on human samples at 1:1000 (fig 3e). J Cancer (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s5l
Cell Signaling Technology Mcl-1 antibody (Cell Signaling Technology, 4572) was used in western blot on human samples (fig s5l). Cell (2019) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; loading ...; fig 3s2e
Cell Signaling Technology Mcl-1 antibody (CST, 5453) was used in western blot on human samples (fig 3s2e). elife (2019) ncbi
domestic rabbit monoclonal (D2W9E)
  • western blot; mouse; loading ...; fig s3d, s6c, s6f
Cell Signaling Technology Mcl-1 antibody (Cell Signaling, 94296) was used in western blot on mouse samples (fig s3d, s6c, s6f). Science (2019) ncbi
domestic rabbit monoclonal (D2W9E)
  • western blot; human; loading ...; fig 3b
Cell Signaling Technology Mcl-1 antibody (Cell Signaling, 94296) was used in western blot on human samples (fig 3b). Cancer Cell Int (2019) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology Mcl-1 antibody (Cell Signaling, 5453) was used in western blot on human samples (fig 4c). Cancer Cell Int (2019) ncbi
domestic rabbit monoclonal (D2W9E)
  • western blot; mouse; 1:1000; loading ...; fig 3a
Cell Signaling Technology Mcl-1 antibody (Cell Signaling Technology, 94296S) was used in western blot on mouse samples at 1:1000 (fig 3a). elife (2018) ncbi
domestic rabbit monoclonal (D2W9E)
Cell Signaling Technology Mcl-1 antibody (Cell Signaling Technology, D2W9E) was used . Methods Mol Biol (2019) ncbi
domestic rabbit monoclonal (D35A5)
  • other; human; loading ...; fig 4c
Cell Signaling Technology Mcl-1 antibody (Cell Signaling, 5453) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; loading ...; fig 3d
Cell Signaling Technology Mcl-1 antibody (Cell Signaling, 5453) was used in western blot on human samples (fig 3d). Sci Rep (2017) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; 1:1000; loading ...; fig s4a
Cell Signaling Technology Mcl-1 antibody (Cell Signaling, 5453) was used in western blot on human samples at 1:1000 (fig s4a). Nat Med (2017) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; 1:1000; loading ...; fig 8a
Cell Signaling Technology Mcl-1 antibody (cell signalling, 5453) was used in western blot on human samples at 1:1000 (fig 8a). Int J Oncol (2017) ncbi
domestic rabbit monoclonal (D2W9E)
  • western blot; mouse; loading ...; fig 5b
Cell Signaling Technology Mcl-1 antibody (Cell Signaling, 94296) was used in western blot on mouse samples (fig 5b). Sci Rep (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1a
In order to observe that chronic presence of internalized Escherichia coli leads to enhanced oncogenicity in colon cancer cells, Cell Signaling Technology Mcl-1 antibody (cell signalling, 4572) was used in western blot on human samples (fig 1a). Cell Death Dis (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5c
Cell Signaling Technology Mcl-1 antibody (Cell Signaling, 4572) was used in western blot on human samples (fig 5c). Oncogene (2017) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; loading ...; fig 10a
In order to study chaperome complexes in a large set of tumor specimens, Cell Signaling Technology Mcl-1 antibody (Cell Signaling, 5453) was used in western blot on human samples (fig 10a). Nature (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5
Cell Signaling Technology Mcl-1 antibody (Cell Signaling Tech, 4572) was used in western blot on human samples (fig 5). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig st1
In order to identify and characterize alterations in signal transduction that occur during the development Lapatinib resistance, Cell Signaling Technology Mcl-1 antibody (Cell Signaling, 4579) was used in western blot on human samples at 1:1000 (fig st1). Nat Commun (2016) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; 1:1000; fig st1
In order to identify and characterize alterations in signal transduction that occur during the development Lapatinib resistance, Cell Signaling Technology Mcl-1 antibody (Cell Signaling, 5453) was used in western blot on human samples at 1:1000 (fig st1). Nat Commun (2016) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; loading ...; fig 7b
Cell Signaling Technology Mcl-1 antibody (Cell Signaling, 5453) was used in western blot on human samples (fig 7b). Cancer Res (2016) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; loading ...; fig s4b
Cell Signaling Technology Mcl-1 antibody (Cell Signaling, 5453) was used in western blot on human samples (fig s4b). Cell Death Dis (2016) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; fig 4
Cell Signaling Technology Mcl-1 antibody (Cell Signaling Technology, 5453) was used in western blot on human samples (fig 4). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; fig 7a
In order to propose that ABHD5 has a PNPLA2-independent function in regulating autophagy and tumorigenesis, Cell Signaling Technology Mcl-1 antibody (Cell Signaling, 5453) was used in western blot on human samples (fig 7a). Autophagy (2016) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; loading ...; fig 4b
Cell Signaling Technology Mcl-1 antibody (Cell Signaling, 5453) was used in western blot on human samples (fig 4b). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; 1:1000; fig 5
Cell Signaling Technology Mcl-1 antibody (Cell Signaling Tech, 5453S) was used in western blot on human samples at 1:1000 (fig 5). Oncol Lett (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4a
Cell Signaling Technology Mcl-1 antibody (Cell Signaling, 4572) was used in western blot on human samples (fig 4a). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4
Cell Signaling Technology Mcl-1 antibody (Cell Signaling, 4572) was used in western blot on human samples (fig 4). Mol Brain (2016) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; mouse; fig 2
Cell Signaling Technology Mcl-1 antibody (Cell Signaling Technolog, 5453) was used in western blot on mouse samples (fig 2). Cell Death Differ (2016) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; mouse; 1:1000; fig 1e
In order to evaluate the antitumor activity of the pan-HDAC inhibitor, panobinostat, in mice, Cell Signaling Technology Mcl-1 antibody (Cell Signaling, 5453) was used in western blot on mouse samples at 1:1000 (fig 1e). Int J Cancer (2016) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; 1:1000; fig 1
In order to investigate the effect of Obatoclax in esophageal cancer cells, Cell Signaling Technology Mcl-1 antibody (Cell Signaling Tech, 5453) was used in western blot on human samples at 1:1000 (fig 1). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig s6
Cell Signaling Technology Mcl-1 antibody (Cell Signaling Tech, 4572S) was used in western blot on human samples (fig s6). Sci Signal (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3
In order to elucidate the deubiquitinase inhibitor PR-619 and how it sensitizes normal human fibroblasts to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cell death, Cell Signaling Technology Mcl-1 antibody (Cell Signaling, 4572) was used in western blot on human samples (fig 3). J Biol Chem (2016) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; fig 6
Cell Signaling Technology Mcl-1 antibody (Cell Signaling, 5453) was used in western blot on human samples (fig 6). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; fig 5
In order to examine the effects of brusatol on the cellular proteome in a mutant non-small cell lung cancer cell line, Cell Signaling Technology Mcl-1 antibody (Cell Signaling Technology, 5453) was used in western blot on human samples (fig 5). Mol Cell Proteomics (2016) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; mouse; fig 5a
Cell Signaling Technology Mcl-1 antibody (Cell Signaling Technology, 5453) was used in western blot on mouse samples (fig 5a). Oncotarget (2015) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 2d
Cell Signaling Technology Mcl-1 antibody (Cell Signaling, 4572) was used in western blot on human samples at 1:1000 (fig 2d). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; 1:500; fig 3
In order to characterize immunogenic PEL cell death, revertion of PEL-induced immune suppression, and stimulation of DCs all triggered by capsaicin, Cell Signaling Technology Mcl-1 antibody (Cell Signaling Technology, 5453P) was used in western blot on human samples at 1:500 (fig 3). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; fig 2b
  • western blot; mouse; fig 2a
In order to utilize an E-mu-TCL1 mouse model to study miR-181b as a therapeutic agent for chronic lymphocytic leukemia, Cell Signaling Technology Mcl-1 antibody (Cell Signaling Technology, 5453) was used in western blot on human samples (fig 2b) and in western blot on mouse samples (fig 2a). Oncotarget (2015) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5g
Cell Signaling Technology Mcl-1 antibody (Cell Signaling Technology, 4572) was used in western blot on human samples (fig 5g). Oncogene (2016) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; mouse; 1:200; fig 9
Cell Signaling Technology Mcl-1 antibody (Cell Signaling, 5453) was used in western blot on mouse samples at 1:200 (fig 9). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; fig s7
Cell Signaling Technology Mcl-1 antibody (CST, 5453) was used in western blot on human samples (fig s7). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; fig 2a
Cell Signaling Technology Mcl-1 antibody (Cell Signaling, D35A5) was used in western blot on human samples (fig 2a). Cancer Lett (2015) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; fig 5
In order to elucidate how PLK1 regulates cell survival during mTORC1 hyperactivation, Cell Signaling Technology Mcl-1 antibody (Cell signaling, 5453) was used in western blot on human samples (fig 5). Cell Cycle (2015) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human
Cell Signaling Technology Mcl-1 antibody (Cell Signaling Technology, 5453) was used in western blot on human samples . Mol Cell Biol (2014) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human
Cell Signaling Technology Mcl-1 antibody (Cell Signaling Technologies, 5453) was used in western blot on human samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; mouse; fig 9
Cell Signaling Technology Mcl-1 antibody (Cell Signaling Technology, 5453) was used in western blot on mouse samples (fig 9). J Neurosci (2013) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; mouse
Cell Signaling Technology Mcl-1 antibody (Cell Signaling, D35A5) was used in western blot on mouse samples . Mol Cancer Ther (2013) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; fig 5
Cell Signaling Technology Mcl-1 antibody (Cell Signaling, 5453) was used in western blot on human samples (fig 5). Cell Cycle (2013) ncbi
BioVision
  • western blot; human; loading ...; fig 6a
BioVision Mcl-1 antibody (Biovision, 3035-100) was used in western blot on human samples (fig 6a). Oncotarget (2015) ncbi
BD Biosciences
mouse monoclonal (22/Mcl-1)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences Mcl-1 antibody (BD Biosciences, 22/Mcl-1) was used in flow cytometry on human samples (fig 1a). Methods Mol Biol (2019) ncbi
mouse monoclonal (22/Mcl-1)
  • western blot; human; 1:1000; loading ...; fig 2a
BD Biosciences Mcl-1 antibody (BD, 559027) was used in western blot on human samples at 1:1000 (fig 2a). Cell Death Dis (2018) ncbi
mouse monoclonal (22/Mcl-1)
  • western blot; human; 1:1000; fig 1c
BD Biosciences Mcl-1 antibody (BD Biosciences, 559027) was used in western blot on human samples at 1:1000 (fig 1c). Front Immunol (2016) ncbi
mouse monoclonal (22/Mcl-1)
  • western blot; human; loading ...; fig 1a
In order to investigate the contributions of Mcl-1 and Bcl-XL during infection with different large DNA viruses, BD Biosciences Mcl-1 antibody (BD Biosciences, 559027) was used in western blot on human samples (fig 1a). Cell Death Dis (2016) ncbi
mouse monoclonal (22/Mcl-1)
  • western blot; human; loading ...; fig 1c
BD Biosciences Mcl-1 antibody (BD Biosciences, 559027) was used in western blot on human samples (fig 1c). Oncotarget (2016) ncbi
mouse monoclonal (22/Mcl-1)
BD Biosciences Mcl-1 antibody (Pharmingen, 559027) was used . Cell Death Dis (2016) ncbi
mouse monoclonal (22/Mcl-1)
  • western blot; human; loading ...; fig st2
BD Biosciences Mcl-1 antibody (BD Bioscience, 559027) was used in western blot on human samples (fig st2). Oncotarget (2015) ncbi
mouse monoclonal (22/Mcl-1)
  • western blot; human; fig 4
BD Biosciences Mcl-1 antibody (BD Bioscience, 559027) was used in western blot on human samples (fig 4). Oncotarget (2015) ncbi
mouse monoclonal (22/Mcl-1)
  • western blot; human; fig 7
BD Biosciences Mcl-1 antibody (BD Pharmingen, 559027) was used in western blot on human samples (fig 7). Chem Biol Drug Des (2015) ncbi
mouse monoclonal (22/Mcl-1)
  • western blot; human; fig 5
BD Biosciences Mcl-1 antibody (Becton Dickinson, 559027) was used in western blot on human samples (fig 5). Oncogene (2015) ncbi
Articles Reviewed
  1. Bhattarai K, Kim H, Chaudhary M, Ur Rashid M, Kim J, Kim H, et al. TMBIM6 regulates redox-associated posttranslational modifications of IRE1α and ER stress response failure in aging mice and humans. Redox Biol. 2021;47:102128 pubmed publisher
  2. Lee S, Jung J, Lee Y, Kim S, Kim J, Kim B, et al. Targeting HSF1 as a Therapeutic Strategy for Multiple Mechanisms of EGFR Inhibitor Resistance in EGFR Mutant Non-Small-Cell Lung Cancer. Cancers (Basel). 2021;13: pubmed publisher
  3. Ecker V, Stumpf M, Brandmeier L, Neumayer T, Pfeuffer L, Engleitner T, et al. Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia. Nat Commun. 2021;12:3526 pubmed publisher
  4. Duan Y, Jia Y, Wang J, Liu T, Cheng Z, Sang M, et al. Long noncoding RNA DGCR5 involves in tumorigenesis of esophageal squamous cell carcinoma via SRSF1-mediated alternative splicing of Mcl-1. Cell Death Dis. 2021;12:587 pubmed publisher
  5. Wojnarowicz P, Escolano M, Huang Y, Desai B, Chin Y, Shah R, et al. Anti-tumor effects of an ID antagonist with no observed acquired resistance. NPJ Breast Cancer. 2021;7:58 pubmed publisher
  6. Campbell K, Mason S, Winder M, Willemsen R, Cloix C, Lawson H, et al. Breast cancer dependence on MCL-1 is due to its canonical anti-apoptotic function. Cell Death Differ. 2021;: pubmed publisher
  7. Zhou X, Chen N, Xu H, Zhou X, Wang J, Fang X, et al. Regulation of Hippo-YAP signaling by insulin-like growth factor-1 receptor in the tumorigenesis of diffuse large B-cell lymphoma. J Hematol Oncol. 2020;13:77 pubmed publisher
  8. Arai S, Varkaris A, Nouri M, Chen S, Xie L, Balk S. MARCH5 mediates NOXA-dependent MCL1 degradation driven by kinase inhibitors and integrated stress response activation. elife. 2020;9: pubmed publisher
  9. Shen S, Dean D, Yu Z, Hornicek F, Kan Q, Duan Z. Aberrant CDK9 expression within chordoma tissues and the therapeutic potential of a selective CDK9 inhibitor LDC000067. J Cancer. 2020;11:132-141 pubmed publisher
  10. Tian M, Gong W, Guo J. Long non-coding RNA SNHG1 indicates poor prognosis and facilitates disease progression in acute myeloid leukemia. Biol Open. 2019;8: pubmed publisher
  11. Zierhut C, Yamaguchi N, Paredes M, Luo J, Carroll T, Funabiki H. The Cytoplasmic DNA Sensor cGAS Promotes Mitotic Cell Death. Cell. 2019;178:302-315.e23 pubmed publisher
  12. Kabir S, Cidado J, Andersen C, Dick C, Lin P, Mitros T, et al. The CUL5 ubiquitin ligase complex mediates resistance to CDK9 and MCL1 inhibitors in lung cancer cells. elife. 2019;8: pubmed publisher
  13. Pan C, Jin L, Wang X, Li Y, Chun J, Boese A, et al. Inositol-triphosphate 3-kinase B confers cisplatin resistance by regulating NOX4-dependent redox balance. J Clin Invest. 2019;129:2431-2445 pubmed publisher
  14. He M, Chaurushiya M, Webster J, Kummerfeld S, Reja R, Chaudhuri S, et al. Intrinsic apoptosis shapes the tumor spectrum linked to inactivation of the deubiquitinase BAP1. Science. 2019;364:283-285 pubmed publisher
  15. Luo H, Jing B, Xia Y, Zhang Y, Hu M, Cai H, et al. WP1130 reveals USP24 as a novel target in T-cell acute lymphoblastic leukemia. Cancer Cell Int. 2019;19:56 pubmed publisher
  16. Liu Y, Wang X, Deng L, Ping L, Shi Y, Zheng W, et al. ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma. Cancer Cell Int. 2019;19:32 pubmed publisher
  17. Dong H, Ye X, Zhong L, Xu J, Qiu J, Wang J, et al. Role of FOXO3 Activated by HIV-1 Tat in HIV-Associated Neurocognitive Disorder Neuronal Apoptosis. Front Neurosci. 2019;13:44 pubmed publisher
  18. LeBlanc L, Lee B, Yu A, Kim M, Kambhampati A, Dupont S, et al. Yap1 safeguards mouse embryonic stem cells from excessive apoptosis during differentiation. elife. 2018;7: pubmed publisher
  19. Smith M, Tahir S. Quantification of BCL-2 Family Members by Flow Cytometry. Methods Mol Biol. 2019;1877:163-172 pubmed publisher
  20. Yue D, Sun X. Idelalisib promotes Bim-dependent apoptosis through AKT/FoxO3a in hepatocellular carcinoma. Cell Death Dis. 2018;9:935 pubmed publisher
  21. Pearce M, Gamble J, Kopparapu P, O Donnell E, Mueller M, Jang H, et al. Induction of apoptosis and suppression of tumor growth by Nur77-derived Bcl-2 converting peptide in chemoresistant lung cancer cells. Oncotarget. 2018;9:26072-26085 pubmed publisher
  22. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  23. Sorokina I, Denisenko T, Imreh G, Tyurin Kuzmin P, Kaminskyy V, Gogvadze V, et al. Involvement of autophagy in the outcome of mitotic catastrophe. Sci Rep. 2017;7:14571 pubmed publisher
  24. Mai W, Gosa L, Daniëls V, Ta L, Tsang J, Higgins B, et al. Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma. Nat Med. 2017;23:1342-1351 pubmed publisher
  25. Nikhil K, Shah K. The Cdk5-Mcl-1 axis promotes mitochondrial dysfunction and neurodegeneration in a model of Alzheimer's disease. J Cell Sci. 2017;130:3023-3039 pubmed publisher
  26. Yokoyama T, Kohn E, Brill E, Lee J. Apoptosis is augmented in high-grade serous ovarian cancer by the combined inhibition of Bcl-2/Bcl-xL and PARP. Int J Oncol. 2017;: pubmed publisher
  27. Lee H, Kim M, Baek M, Morales L, Jang I, Slaga T, et al. Targeted disruption of TC-PTP in the proliferative compartment augments STAT3 and AKT signaling and skin tumor development. Sci Rep. 2017;7:45077 pubmed publisher
  28. Sahu U, Choudhury A, Parvez S, Biswas S, Kar S. Induction of intestinal stemness and tumorigenicity by aberrant internalization of commensal non-pathogenic E. coli. Cell Death Dis. 2017;8:e2667 pubmed publisher
  29. Cayrol F, Praditsuktavorn P, Fernando T, Kwiatkowski N, Marullo R, Calvo Vidal M, et al. THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors. Nat Commun. 2017;8:14290 pubmed publisher
  30. Guo A, Lu P, Lee J, Zhen C, Chiosis G, Wang Y. HSP90 stabilizes B-cell receptor kinases in a multi-client interactome: PU-H71 induces CLL apoptosis in a cytoprotective microenvironment. Oncogene. 2017;36:3441-3449 pubmed publisher
  31. Adams C, Kim A, Mitra R, Choi J, Gong J, Eischen C. BCL-W has a fundamental role in B cell survival and lymphomagenesis. J Clin Invest. 2017;127:635-650 pubmed publisher
  32. Pandey R, Mehrotra S, Sharma S, Gudde R, Sundar S, Shaha C. Leishmania donovani-Induced Increase in Macrophage Bcl-2 Favors Parasite Survival. Front Immunol. 2016;7:456 pubmed
  33. Rodina A, Wang T, Yan P, Gomes E, Dunphy M, Pillarsetty N, et al. The epichaperome is an integrated chaperome network that facilitates tumour survival. Nature. 2016;538:397-401 pubmed publisher
  34. Zhang Y, Zhang Y, Zhong C, Xiao F. Cr(VI) induces premature senescence through ROS-mediated p53 pathway in L-02 hepatocytes. Sci Rep. 2016;6:34578 pubmed publisher
  35. Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed publisher
  36. Horn T, Ferretti S, Ebel N, Tam A, Ho S, Harbinski F, et al. High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells. Cancer Res. 2016;76:6950-6963 pubmed
  37. Klingbeil O, Lesche R, Gelato K, Haendler B, Lejeune P. Inhibition of BET bromodomain-dependent XIAP and FLIP expression sensitizes KRAS-mutated NSCLC to pro-apoptotic agents. Cell Death Dis. 2016;7:e2365 pubmed publisher
  38. Park S, Jo D, Jo S, Shin D, Shim S, Jo Y, et al. Inhibition of never in mitosis A (NIMA)-related kinase-4 reduces survivin expression and sensitizes cancer cells to TRAIL-induced cell death. Oncotarget. 2016;7:65957-65967 pubmed publisher
  39. Peng Y, Miao H, Wu S, Yang W, Zhang Y, Xie G, et al. ABHD5 interacts with BECN1 to regulate autophagy and tumorigenesis of colon cancer independent of PNPLA2. Autophagy. 2016;12:2167-2182 pubmed
  40. Ohmer M, Weber A, Sutter G, Ehrhardt K, Zimmermann A, Häcker G. Anti-apoptotic Bcl-XL but not Mcl-1 contributes to protection against virus-induced apoptosis. Cell Death Dis. 2016;7:e2340 pubmed publisher
  41. Weyhenmeyer B, Noonan J, Würstle M, Lincoln F, Johnston G, Rehm M, et al. Predicting the cell death responsiveness and sensitization of glioma cells to TRAIL and temozolomide. Oncotarget. 2016;7:61295-61311 pubmed publisher
  42. Liu H, Li W, Yu X, Gao F, Duan Z, Ma X, et al. EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis. Oncotarget. 2016;7:56338-56354 pubmed publisher
  43. Bao H, Liu P, Jiang K, Zhang X, Xie L, Wang Z, et al. Huaier polysaccharide induces apoptosis in hepatocellular carcinoma cells through p38 MAPK. Oncol Lett. 2016;12:1058-1066 pubmed
  44. Gao Z, Liu Z, Bi M, Zhang J, Han Z, Han X, et al. Metformin induces apoptosis via a mitochondria-mediated pathway in human breast cancer cells in vitro. Exp Ther Med. 2016;11:1700-1706 pubmed
  45. Zhao J, Niu X, Li X, Edwards H, Wang G, Wang Y, et al. Inhibition of CHK1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells. Oncotarget. 2016;7:34785-99 pubmed publisher
  46. Wang W, Zhan M, Li Q, Chen W, Chu H, Huang Q, et al. FXR agonists enhance the sensitivity of biliary tract cancer cells to cisplatin via SHP dependent inhibition of Bcl-xL expression. Oncotarget. 2016;7:34617-29 pubmed publisher
  47. Kim H, Oh J, Choi S, Nam Y, Jo A, Kwon A, et al. Down-regulation of p21-activated serine/threonine kinase 1 is involved in loss of mesencephalic dopamine neurons. Mol Brain. 2016;9:45 pubmed publisher
  48. Barroso González J, Auclair S, Luan S, Thomas L, Atkins K, Aslan J, et al. PACS-2 mediates the ATM and NF-κB-dependent induction of anti-apoptotic Bcl-xL in response to DNA damage. Cell Death Differ. 2016;23:1448-57 pubmed publisher
  49. Waldeck K, Cullinane C, Ardley K, Shortt J, Martin B, Tothill R, et al. Long term, continuous exposure to panobinostat induces terminal differentiation and long term survival in the TH-MYCN neuroblastoma mouse model. Int J Cancer. 2016;139:194-204 pubmed publisher
  50. Yu L, Wu W, Gu C, Zhong D, Zhao X, Kong Y, et al. Obatoclax impairs lysosomal function to block autophagy in cisplatin-sensitive and -resistant esophageal cancer cells. Oncotarget. 2016;7:14693-707 pubmed publisher
  51. Kline C, van den Heuvel A, Allen J, Prabhu V, Dicker D, El Deiry W. ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2α kinases. Sci Signal. 2016;9:ra18 pubmed publisher
  52. De Toni E, Ziesch A, Rizzani A, Török H, Hocke S, Lü S, et al. Inactivation of BRCA2 in human cancer cells identifies a subset of tumors with enhanced sensitivity towards death receptor-mediated apoptosis. Oncotarget. 2016;7:9477-90 pubmed publisher
  53. Lopez J, Bessou M, Riley J, Giampazolias E, Todt F, Rochegüe T, et al. Mito-priming as a method to engineer Bcl-2 addiction. Nat Commun. 2016;7:10538 pubmed publisher
  54. Menter T, Dickenmann M, Juskevicius D, Steiger J, Dirnhofer S, Tzankov A. Comprehensive phenotypic characterization of PTLD reveals potential reliance on EBV or NF-κB signalling instead of B-cell receptor signalling. Hematol Oncol. 2017;35:187-197 pubmed publisher
  55. Wolfsperger F, Hogh Binder S, Schittenhelm J, Psaras T, Ritter V, Bornes L, et al. Deubiquitylating enzyme USP9x regulates radiosensitivity in glioblastoma cells by Mcl-1-dependent and -independent mechanisms. Cell Death Dis. 2016;7:e2039 pubmed publisher
  56. Crowder R, Dicker D, El Deiry W. The Deubiquitinase Inhibitor PR-619 Sensitizes Normal Human Fibroblasts to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-mediated Cell Death. J Biol Chem. 2016;291:5960-70 pubmed publisher
  57. Lub S, Maes A, Maes K, De Veirman K, De Bruyne E, Menu E, et al. Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells. Oncotarget. 2016;7:4062-76 pubmed publisher
  58. Vartanian S, Ma T, Lee J, Haverty P, Kirkpatrick D, Yu K, et al. Application of Mass Spectrometry Profiling to Establish Brusatol as an Inhibitor of Global Protein Synthesis. Mol Cell Proteomics. 2016;15:1220-31 pubmed publisher
  59. Wang J, De Veirman K, De Beule N, Maes K, De Bruyne E, Van Valckenborgh E, et al. The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells. Oncotarget. 2015;6:43992-4004 pubmed publisher
  60. Ko T, Chin H, Chuah C, Huang J, Ng K, Khaw S, et al. The BIM deletion polymorphism: A paradigm of a permissive interaction between germline and acquired TKI resistance factors in chronic myeloid leukemia. Oncotarget. 2016;7:2721-33 pubmed publisher
  61. Bailey M, Singh T, Mero P, Moffat J, Hieter P. Dependence of Human Colorectal Cells Lacking the FBW7 Tumor Suppressor on the Spindle Assembly Checkpoint. Genetics. 2015;201:885-95 pubmed publisher
  62. Granato M, Gilardini Montani M, Filardi M, Faggioni A, Cirone M. Capsaicin triggers immunogenic PEL cell death, stimulates DCs and reverts PEL-induced immune suppression. Oncotarget. 2015;6:29543-54 pubmed publisher
  63. Lavik A, Zhong F, Chang M, Greenberg E, Choudhary Y, Smith M, et al. A synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting the BH3-binding pocket of Bcl-2. Oncotarget. 2015;6:27388-402 pubmed publisher
  64. Tiffen J, Gunatilake D, Gallagher S, Gowrishankar K, Heinemann A, Cullinane C, et al. Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes. Oncotarget. 2015;6:27023-36 pubmed publisher
  65. Bresin A, Callegari E, D Abundo L, Cattani C, Bassi C, Zagatti B, et al. miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model. Oncotarget. 2015;6:19807-18 pubmed
  66. Heinemann A, Cullinane C, De Paoli Iseppi R, Wilmott J, Gunatilake D, Madore J, et al. Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling. Oncotarget. 2015;6:21507-21 pubmed
  67. Fedorenko I, Abel E, Koomen J, Fang B, Wood E, Chen Y, et al. Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells. Oncogene. 2016;35:1225-35 pubmed publisher
  68. Nagata T, Yasukawa H, Kyogoku S, Oba T, Takahashi J, Nohara S, et al. Cardiac-Specific SOCS3 Deletion Prevents In Vivo Myocardial Ischemia Reperfusion Injury through Sustained Activation of Cardioprotective Signaling Molecules. PLoS ONE. 2015;10:e0127942 pubmed publisher
  69. Martínez A, Sesé M, Losa J, Robichaud N, Sonenberg N, Aasen T, et al. Phosphorylation of eIF4E Confers Resistance to Cellular Stress and DNA-Damaging Agents through an Interaction with 4E-T: A Rationale for Novel Therapeutic Approaches. PLoS ONE. 2015;10:e0123352 pubmed publisher
  70. Gupta J, Igea A, Papaioannou M, López Casas P, Llonch E, Hidalgo M, et al. Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumors. Oncotarget. 2015;6:8539-51 pubmed
  71. Wang X, D Arcy P, Caulfield T, Paulus A, Chitta K, Mohanty C, et al. Synthesis and evaluation of derivatives of the proteasome deubiquitinase inhibitor b-AP15. Chem Biol Drug Des. 2015;86:1036-48 pubmed publisher
  72. Yang N, Han F, Cui H, Huang J, Wang T, Zhou Y, et al. Matrine suppresses proliferation and induces apoptosis in human cholangiocarcinoma cells through suppression of JAK2/STAT3 signaling. Pharmacol Rep. 2015;67:388-93 pubmed publisher
  73. Cui J, Sun W, Hao X, Wei M, Su X, Zhang Y, et al. EHMT2 inhibitor BIX-01294 induces apoptosis through PMAIP1-USP9X-MCL1 axis in human bladder cancer cells. Cancer Cell Int. 2015;15:4 pubmed publisher
  74. Long J, Schoonen P, Graczyk D, O Prey J, Ryan K. p73 engages A2B receptor signalling to prime cancer cells to chemotherapy-induced death. Oncogene. 2015;34:5152-62 pubmed publisher
  75. Lu K, Fang X, Feng L, Jiang Y, Zhou X, Liu X, et al. The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6. Cancer Lett. 2015;359:250-8 pubmed publisher
  76. Valianou M, Cox A, Pichette B, Hartley S, Paladhi U, Astrinidis A. Pharmacological inhibition of Polo-like kinase 1 (PLK1) by BI-2536 decreases the viability and survival of hamartin and tuberin deficient cells via induction of apoptosis and attenuation of autophagy. Cell Cycle. 2015;14:399-407 pubmed publisher
  77. Yan J, Zhong N, Liu G, Chen K, Liu X, Su L, et al. Usp9x- and Noxa-mediated Mcl-1 downregulation contributes to pemetrexed-induced apoptosis in human non-small-cell lung cancer cells. Cell Death Dis. 2014;5:e1316 pubmed publisher
  78. Waitkus M, Chandrasekharan U, Willard B, Tee T, Hsieh J, Przybycin C, et al. Signal integration and gene induction by a functionally distinct STAT3 phosphoform. Mol Cell Biol. 2014;34:1800-11 pubmed publisher
  79. Yoon H, Choi Y, Song J, Do I, Kang S, Ko Y, et al. Targeted inhibition of FAK, PYK2 and BCL-XL synergistically enhances apoptosis in ovarian clear cell carcinoma cell lines. PLoS ONE. 2014;9:e88587 pubmed publisher
  80. Annibaldi A, Heulot M, Martinou J, Widmann C. TAT-RasGAP317-326-mediated tumor cell death sensitization can occur independently of Bax and Bak. Apoptosis. 2014;19:719-33 pubmed publisher
  81. Crowther A, Gama V, Bevilacqua A, Chang S, Yuan H, Deshmukh M, et al. Tonic activation of Bax primes neural progenitors for rapid apoptosis through a mechanism preserved in medulloblastoma. J Neurosci. 2013;33:18098-108 pubmed publisher
  82. Peng Y, Shi Y, Ding Z, Ke A, Gu C, Hui B, et al. Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells. Autophagy. 2013;9:2056-68 pubmed publisher
  83. Ma T, Galimberti F, Erkmen C, Memoli V, Chinyengetere F, SEMPERE L, et al. Comparing histone deacetylase inhibitor responses in genetically engineered mouse lung cancer models and a window of opportunity trial in patients with lung cancer. Mol Cancer Ther. 2013;12:1545-55 pubmed publisher
  84. Carra E, Barbieri F, Marubbi D, Pattarozzi A, Favoni R, Florio T, et al. Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures. Cell Cycle. 2013;12:491-500 pubmed publisher
  85. Son J, Varadarajan S, Bratton S. TRAIL-activated stress kinases suppress apoptosis through transcriptional upregulation of MCL-1. Cell Death Differ. 2010;17:1288-301 pubmed publisher